Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Sarcoma, Ewing 1Rhabdomyosarcoma 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Ependymoma 1Craniopharyngioma 1

Interventions

Cyclophosphamide 42fludarabine phosphate 33Peripheral Blood Stem Cell Transplantation 32Mycophenolic Acid 26Whole-Body Irradiation 23Cyclosporine 23Busulfan 23Radiotherapy 19Filgrastim 19Antilymphocyte Serum 19Tacrolimus 16Melphalan 16Methotrexate 12Methylprednisolone 10Cord Blood Stem Cell Transplantation 10Etoposide 8Thiotepa 6sargramostim 5fludarabine 5Therapeutics 5aldesleukin 4Sirolimus 4Cytarabine 4Polymerase Chain Reaction 3Paclitaxel 3Granulocyte Colony-Stimulating Factor 3Carmustine 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Methionine × Sarcoma × Clear all
NCT00840047 2026-04-24

Methionine PET/CT Studies In Patients With Cancer

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
503 enrolled
CNSLymphoidSarcoma

Craniopharyngioma, Ependymoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡